NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

You must not have much background in drug pricing then. It is a rare disease, manufacturing costs are high, free drug and patients support programs get baked into the US price as well as the US subsidizing smaller markets that can’t really afford Western medicine. You need to finance corporate infrastructure build both brick and mortar as well as human capital, and more importantly you need to finance R&D and product improvements. Oh yeah, we all invested so there is also a thing called profit.

CAR-Ts cost way more as do most all other orphan biotech disease drugs recently developed. If you buy the CAR-Ts are so expensive to manufacture there is barely any profit margin line, I have some beachfront property in The Florida Keys to sell you. Good luck reselling that in ten years. The tax burden from the conservative Cost estimates to raise the highways and bridges alone are going to sink that value to nothing.